keyboard_arrow_up

Biosimilar Manufacturing Outsourcing is a Key Trend Affecting the Global Biosimilars Market

Reportstack has announced a new market research publication on Global Biosimilars Market which finds emergence of Biosimilar Manufacturing Outsourcing as a key trend affecting this market. The analysis is for the forecast period 2014-2018.

The manufacture of biosimilar products requires specialized capabilities, meticulous planning, highly skilled staff, and significant financial investment in equipment, technology, materials, and personnel. Therefore, the complexities and costs involved in the biosimilar development rises along with the dip in their profit margins, hampering the overall success of manufacturing biosimilar products. Thus, many vendors are increasingly turning to CMOs and CROs that have already gained proficiency in the field of manufacturing biosimilar products.

The wealth of knowledge, experience, understanding, technology, skills and financial control that CMOs and CROs are providing to manufacturers, make this a solution that many vendors are using at present. These organizations employ well-trained professionals for developing and validating analytical methods, providing pharmaceutical companies with a feasible way of remaining competitive and financially viable.

Moreover, manufacturing biosimilar products in developing countries such as India and China has reduced the requisite investment by about 40 percent, making India and China a hub for outsourced biosimilar manufacturing. Thus, the outsourcing of biosimilar product manufacture to developing nations would enable market vendors to achieve the quickest and most cost-effective method of getting a new product to market. This new trend will be having a positive impact on the growth of the market over the next few years.

To determine the scenario for these vendors in the next 3-4 years, the analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentation, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance. 

To view the table of contents and know more details please visit http://www.reportstack.com/product/150774/global-biosimilars-market-2014-2018.html